Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Syngene International Ltd

NSE: SYNGENE · BSE: 539268 · Pharmaceuticals & Biotechnology · 38 announcements

Share price
₹361.90
Market cap
₹14,609 Cr
Revenue (annual)
₹3,739 Cr
Net profit (annual)
₹316.7 Cr
P/E (TTM)
66.1×Sector 47.4×
Promoter holding
52.59%-0.09% QoQ
FII holding
11.82%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:32 IST NSE
Board Meeting Outcome

Syngene International Board Meeting Outcome

Syngene International Limited's board approved the appointment of Mr. Vijaya Chandru and Mr. Arun Chandavarkar as Independent Directors for three-year terms starting July 2026. Additionally, Ms. Vinita Bali was appointed as a Non-Executive Director for a one-year term. These appointments bring significant expertise in biotechnology, AI, and global business leadership to the board.

17:50 IST NSE
Board Meeting Outcome

Syngene International Board Meeting Outcome

Syngene International Limited has scheduled a Board Meeting on April 29, 2026, to consider audited standalone and consolidated financial results for the year ended March 31, 2026. The board will also recommend a final dividend. Trading windows remain closed from April 1 until May 1, 2026.

17:49 IST BSE
Board Meeting Outcome

Syngene International Board Meeting Outcome

Syngene International Ltd will hold a Board Meeting on April 29, 2026, to approve audited financial results for the quarter and year ending March 31, 2026. The board will also consider recommending a final dividend. Consequently, the trading window is closed from April 01 to May 01, 2026.